-
Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert PanelJE Wilcox, JC Fang, KB Margulies et al. -
Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failureHC Chang, CJ Huang, HM Cheng et al.
-
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility ModulationAbraham WT, Kuck KH, FIX-HF-5 Investigators and Coordinators.
-
Lifestyle Modifications for Preventing and Treating Heart FailureM Aggarwal, B Bozkurt, on behalf of American College of Cardiology’s Nutrition and Lifestyle Committee of the Prevention of Cardiovascular Disease Council.
-
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-ReducedF Zannad, JP Ferreira, SJ Pocock et al.
-
Longitudinal Change in Galectin-3 and Incident Cardiovascular OutcomesA Ghorbani, V Bhambhani, RH Christenson et al.
-
Association of Cardiovascular Disease With Respiratory DiseaseP Carter, J Lagan, C Fortune et al.
-
Dapagliflozin for treating chronic heart failure with reduced ejection fractionNational Institue for Health and Care Excellence
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
